Literature DB >> 16630258

The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii.

Jane F Turton1, M Elaina Ward, Neil Woodford, Mary E Kaufmann, Rachel Pike, David M Livermore, Tyrone L Pitt.   

Abstract

ISAba1 was found in all widespread clones of Acinetobacter baumannii in the United Kingdom. All isolates studied had a blaOXA-51-like carbapenemase gene; some also had blaOXA-23-like and/or blaOXA-58-like. Among isolates with blaOXA-51-like as sole carbapenemase gene, only those with ISAba1 adjacent to blaOXA-51-like were carbapenem resistant. Minor differences in blaOXA-51-like sequence were observed in resistant and susceptible isolates. Isolates with blaOXA-23-like in addition were consistently resistant to carbapenems; in all of these ISAba1 lay upstream of blaOXA-23-like, but was not associated with blaOXA-51-like. These results suggest that ISAba1 is providing the promoter for blaOXA-51-like and, probably, for blaOXA-23-like.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16630258     DOI: 10.1111/j.1574-6968.2006.00195.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  218 in total

1.  In vivo selection of a missense mutation in adeR and conversion of the novel blaOXA-164 gene into blaOXA-58 in carbapenem-resistant Acinetobacter baumannii isolates from a hospitalized patient.

Authors:  Paul G Higgins; Thamarai Schneiders; Axel Hamprecht; Harald Seifert
Journal:  Antimicrob Agents Chemother       Date:  2010-10-04       Impact factor: 5.191

2.  High prevalence of carbapenem-resistant Acinetobacter baumannii carrying the blaOXA-143 gene in Brazilian hospitals.

Authors:  Charline S Antonio; Patrícia R Neves; Micheli Medeiros; Elsa M Mamizuka; Maria R Elmor de Araújo; Nilton Lincopan
Journal:  Antimicrob Agents Chemother       Date:  2010-12-13       Impact factor: 5.191

3.  Drug-resistant gene of blaOXA-23, blaOXA-24, blaOXA-51 and blaOXA-58 in Acinetobacter baumannii.

Authors:  Chenggong Hou; Feng Yang
Journal:  Int J Clin Exp Med       Date:  2015-08-15

4.  A Diverse Panel of Clinical Acinetobacter baumannii for Research and Development.

Authors:  Madeline R Galac; Erik Snesrud; Francois Lebreton; Jason Stam; Michael Julius; Ana C Ong; Rosslyn Maybank; Anthony R Jones; Yoon I Kwak; Kate Hinkle; Paige E Waterman; Emil P Lesho; Jason W Bennett; Patrick Mc Gann
Journal:  Antimicrob Agents Chemother       Date:  2020-09-21       Impact factor: 5.191

5.  Occurrence of an environmental Acinetobacter baumannii strain similar to a clinical isolate in paleosol from Croatia.

Authors:  Jasna Hrenovic; Goran Durn; Ivana Goic-Barisic; Ana Kovacic
Journal:  Appl Environ Microbiol       Date:  2014-02-28       Impact factor: 4.792

Review 6.  Treatment options for carbapenem-resistant and extensively drug-resistant Acinetobacter baumannii infections.

Authors:  J Alexander Viehman; M Hong Nguyen; Yohei Doi
Journal:  Drugs       Date:  2014-08       Impact factor: 9.546

7.  Disruption of tetR type regulator adeN by mobile genetic element confers elevated virulence in Acinetobacter baumannii.

Authors:  Rajagopalan Saranathan; Sudhakar Pagal; Ajit R Sawant; Archana Tomar; M Madhangi; Suresh Sah; Annapurna Satti; K P Arunkumar; K Prashanth
Journal:  Virulence       Date:  2017-04-24       Impact factor: 5.882

8.  Evolution of carbapenem-resistant Acinetobacter baumannii revealed through whole-genome sequencing and comparative genomic analysis.

Authors:  Henan Li; Fei Liu; Yawei Zhang; Xiaojuan Wang; Chunjiang Zhao; Hongbin Chen; Feifei Zhang; Baoli Zhu; Yongfei Hu; Hui Wang
Journal:  Antimicrob Agents Chemother       Date:  2014-12-08       Impact factor: 5.191

9.  OXA-143, a novel carbapenem-hydrolyzing class D beta-lactamase in Acinetobacter baumannii.

Authors:  Paul G Higgins; Laurent Poirel; Marlene Lehmann; Patrice Nordmann; Harald Seifert
Journal:  Antimicrob Agents Chemother       Date:  2009-09-21       Impact factor: 5.191

10.  Bacteremia due to Acinetobacter genomic species 10.

Authors:  Shu-Chen Kuo; Chang-Phone Fung; Yi-Tzu Lee; Chien-Pei Chen; Te-Li Chen
Journal:  J Clin Microbiol       Date:  2009-12-02       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.